Expert Videos & Resources
The following video chapters were previously recorded as part of a live, national broadcast event. Expert oncologists review the results of the NAPOLI-1 Phase 3 trial that supported the approval of ONIVYDE® (irinotecan liposome injection) and share details about the key efficacy, safety, and recommended dosing information. They will also present a patient case study and discuss the potential integration of this therapy into clinical practice.
In the Resources section below these videos, please review the published NAPOLI-1 study in The Lancet. If you do not have individual or institutional access to this journal, please contact us for a copy of the article.